Snail Overexpression Alters the microRNA Content of Extracellular Vesicles Released from HT29 Colorectal Cancer Cells and Activates Pro-Inflammatory State In Vivo.

Snail transcription factor colon cancer extracellular vesicles pre-metastatic niche

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
06 Jan 2021
Historique:
received: 09 10 2020
revised: 22 12 2020
accepted: 29 12 2020
entrez: 9 1 2021
pubmed: 10 1 2021
medline: 10 1 2021
Statut: epublish

Résumé

During metastasis, cancer cells undergo phenotype changes in the epithelial-mesenchymal transition (EMT) process. Extracellular vesicles (EVs) released by cancer cells are the mediators of intercellular communication and play a role in metastatic process. Knowledge of factors that influence the modifications of the pre-metastatic niche for the migrating carcinoma cells is important for prevention of metastasis. We focus here on how cancer progression is affected by EVs released from either epithelial-like HT29-cells or from cells that are in early EMT stage triggered by Snail transcription factor (HT29-Snail). We found that EVs released from HT29-Snail, as compared to HT29-pcDNA cells, have a different microRNA profile. We observed the presence of interstitial pneumonias in the lungs of mice injected with HT29-Snail cells and the percent of mice with lung inflammation was higher after injection of HT29-Snail-EVs. Incorporation of EVs released from HT29-pcDNA, but not released from HT29-Snail, leads to the increased secretion of IL-8 from macrophages. We conclude that Snail modifications of CRC cells towards more invasive phenotype also alter the microRNA cargo of released EVs. The content of cell-released EVs may serve as a biomarker that denotes the stage of CRC and EVs-specific microRNAs may be a target to prevent cancer progression.

Identifiants

pubmed: 33419021
pii: cancers13020172
doi: 10.3390/cancers13020172
pmc: PMC7830966
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Science Centre, Cracow, Poland
ID : 2011/02/A/NZ3/00068
Organisme : National Science Centre, Cracow, Poland
ID : 2018/29/B/NZ5/01756
Organisme : National Science Centre, Cracow, Poland
ID : 2016/22/E/NZ3/00341
Organisme : IBM PAS Statutory Funds
ID : 2016-2019

Références

Neoplasia. 2013 Sep;15(9):1086-99
pubmed: 24027433
J Exp Clin Cancer Res. 2018 Jul 9;37(1):143
pubmed: 29986759
Biochim Biophys Acta Rev Cancer. 2018 Jan;1869(1):64-77
pubmed: 29175553
Cancer Inform. 2014 Dec 09;13(Suppl 4):65-72
pubmed: 25574127
Pharmacol Ther. 2016 Dec;168:98-112
pubmed: 27613100
Bioscience. 2015 Aug 1;65(8):783-797
pubmed: 26955082
FEBS J. 2015 Apr;282(7):1289-306
pubmed: 25639683
Cells. 2020 Jun 30;9(7):
pubmed: 32629890
Nat Commun. 2011;2:282
pubmed: 21505438
PLoS One. 2016 Jun 06;11(6):e0156871
pubmed: 27271572
Cells. 2018 Aug 01;7(8):
pubmed: 30071693
Elife. 2015 Jul 01;4:e07197
pubmed: 26132860
Postepy Hig Med Dosw (Online). 2016 Sep 19;70(0):968-980
pubmed: 27668649
PLoS One. 2019 Jan 4;14(1):e0210003
pubmed: 30608951
World J Urol. 2014 Apr;32(2):353-8
pubmed: 23266581
PLoS One. 2012;7(5):e35661
pubmed: 22623952
Oncotarget. 2016 Jul 12;7(28):43076-43087
pubmed: 27172798
Sci Rep. 2019 Feb 15;9(1):2165
pubmed: 30770873
Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
pubmed: 16461460
J Immunol. 1993 Jun 1;150(11):5025-32
pubmed: 8496603
Semin Cancer Biol. 2014 Oct;28:14-23
pubmed: 24783980
PLoS One. 2014 Feb 03;9(2):e87938
pubmed: 24498407
Cancer Cell. 2016 Nov 14;30(5):668-681
pubmed: 27846389
Cancer Cell. 2014 Oct 13;26(4):534-48
pubmed: 25314079
PLoS One. 2012;7(4):e35440
pubmed: 22514743
Cells. 2019 Jul 15;8(7):
pubmed: 31311206
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Immunol Cell Biol. 2018 Mar 25;:
pubmed: 29575270
J Immunol. 2007 Aug 1;179(3):1969-78
pubmed: 17641064
Oncogene. 2013 Jul 4;32(27):3286-95
pubmed: 22847613
Mol Cell Endocrinol. 2014 Jun 5;390(1-2):1-7
pubmed: 24681352
Cancer Res. 2016 Jul 1;76(13):3666-70
pubmed: 27325641
Lancet. 2014 Apr 26;383(9927):1490-1502
pubmed: 24225001
Cancer Cell. 2016 Dec 12;30(6):836-848
pubmed: 27960084
Br J Cancer. 2013 Jul 9;109(1):138-46
pubmed: 23756862
Oncol Lett. 2016 Dec;12(6):4937-4948
pubmed: 28105201
Cell Tissue Res. 2013 Jan;351(1):85-98
pubmed: 23111773
J Inflamm (Lond). 2005 Oct 31;2:14
pubmed: 16259633
Cell Res. 2008 Oct;18(10):997-1006
pubmed: 18766170
Cancer Res. 2006 Dec 1;66(23):11089-93
pubmed: 17145848
Int J Clin Exp Pathol. 2018 Dec 01;11(12):5735-5744
pubmed: 31949659
Biomed Pharmacother. 2018 Jun;102:1203-1208
pubmed: 29710539
Asian Pac J Cancer Prev. 2014;15(9):4033-7
pubmed: 24935592
Front Physiol. 2018 Jun 05;9:651
pubmed: 29922170
Annu Rev Med. 2009;60:167-79
pubmed: 19630570
Cell Cycle. 2011 Dec 15;10(24):4256-71
pubmed: 22134354
Biochim Biophys Acta. 2016 Nov;1860(11 Pt A):2445-2453
pubmed: 27450890
Endocr Relat Cancer. 2010 Jan 29;17(1):F19-36
pubmed: 19779035
Front Immunol. 2018 Apr 30;9:738
pubmed: 29760691
Int J Oncol. 2016 Jan;48(1):305-12
pubmed: 26647805
Cells. 2019 Feb 27;8(3):
pubmed: 30818851

Auteurs

Izabela Papiewska-Pająk (I)

Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.

Patrycja Przygodzka (P)

Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.

Damian Krzyżanowski (D)

Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.

Kamila Soboska (K)

Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.
Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland.

Izabela Szulc-Kiełbik (I)

Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.

Olga Stasikowska-Kanicka (O)

Department of Diagnostic Techniques in Pathomorphology, Medical University of Lodz, 90-419 Lodz, Poland.

Joanna Boncela (J)

Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.

Małgorzata Wągrowska-Danilewicz (M)

Department of Diagnostic Techniques in Pathomorphology, Medical University of Lodz, 90-419 Lodz, Poland.

M Anna Kowalska (MA)

Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.
Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Classifications MeSH